COVID-19 Therapeutic Drug Development

Various research strategies are being deployed to control the COVID-19 pandemic, including a search for a vaccine. This feed covers primarily the ongoing research efforts that are focused on repurposing existing antiviral drugs and finding novel therapeutic treatments.

May 31, 2020

Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Shuofeng YuanKwok-Yung Yuen
June 1, 2020

Risk of using hydroxychloroquine as a treatment of COVID-19

The International Journal of Risk & Safety in Medicine
Lo'ai AlanagrehManar Atoum
May 31, 2020

Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial

The Journal of Antimicrobial Chemotherapy
Minh P LêC-20–15 DisCoVeRy French Steering Committee
May 29, 2020

Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Dorothy H J CheongThai Tran
May 31, 2020

Treatment algorithm for COVID-19: a multidisciplinary point of view

Clinical Rheumatology
Felice GalluccioMario Fajardo-Pérez
May 30, 2020

Emerging pharmacotherapies for COVID-19

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Rachana Salvi, Panini Patankar
May 28, 2020
Open Access

Chloroquine, hydroxychloroquine and COVID-19

Toxicology Communications
T B EricksonE W Boyer
June 1, 2020

Lopinavir/ritonavir use in Covid-19 infection: is it completely non-beneficial?

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
Adewale Bayode Owa, Olufunke Tolulope Owa
May 28, 2020

Synergistic effect of Vitamin D and Remdesivir can fight COVID-19

Journal of Biomolecular Structure & Dynamics
Aditya Arya, Vivek Dhar Dwivedi
May 28, 2020

Patients with bullous disorders during COVID-19 period: management and adherence to treatment

Dermatologic Therapy
Gaia De Fata SalvatoresAdriana Di Guida
May 29, 2020

Chloroquine or Hydroxychloroquine for COVID-19: Is Cardiotoxicity a Concern?

Journal of the American Heart Association
Timothy J KampCraig T January
June 1, 2020

Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence

M RoustitFrench Society of Pharmacology and Therapeutics (SFPT)
May 29, 2020
Open Access

COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area

Breast Cancer Research : BCR
Perrine VuagnatFrançois-Clément Bidard
June 1, 2020

Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients

Travel Medicine and Infectious Disease
Khalid Eljaaly, Jaffar A Al-Tawfiq
June 1, 2020

Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment

Clinical Rheumatology
Mehmet SoyServet Kayhan

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

© 2020 Meta ULC. All rights reserved